Search

everythinglearnresearchcommunity

for

Search:↓

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Apremilast shows promise for several skin conditions but needs more research.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

Pranlukast and mirabegron may work as new diabetes drugs.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Bidirectional barbed sutures are effective and can reduce surgery time, with a low infection rate and potential cost savings despite being more expensive.

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Most Facebook posts about hair loss treatments are promotional and not medically supported, with better quality information found on YouTube.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Stem cells could be a better treatment for hair loss by reactivating dormant hair follicles.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Follicular unit transplantation treats hair loss and restores eyebrows with short recovery and natural results.

The herbal hair oil effectively promotes hair growth, nourishes the scalp, and prevents dandruff.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

New small molecule drugs could help treat hair loss.

Exosomes could improve skin and hair treatments, but more research and regulation are needed.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The paper concludes that drug labels should be clear for all, especially for those with low literacy, and suggests aiming for high comprehension test passing rates with diverse test populations.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.